Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.

By D. Baeten, J. Sieper, J. Braun, X. Baraliakos, M. Dougados, P. Emery, A. Deodhar, B. Porter, Ruvie Martin, M. Andersson and 2 more. New England Journal of Medicine, 2015

916 citations recorded by the source corpus.

Subfields: Immunology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/82472970f056c07ccf232a18b6c182c6ffea5e0a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. S. Gaffen
2. D. Cua
3. M. McGeachy
4. R. Flavell
5. Ming O. Li
6. C. Tato

In Rheumatology

1. S. Gaffen

Citations in the corpus

• The IL-17 family of cytokines in health and disease (2019, background): “, 2014; Mease and McInnes, 2016) as well as ankylosing spondylitis (AS), a disease with previously poor therapeutic options (Baeten et al., 2015; van Mens et al., 2018).”